Related Experiment Video
Updated: Jul 15, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
COVID-19 and cardiovascular disease in patients with chronic kidney disease
Lucia Del Vecchio1, Olga Balafa2, Evangelia Dounousi3
1Department of Nephrology and Dialysis, Sant'Anna Hospital, ASST Lariana, Como, Italy.
Insights
Chronic kidney disease (CKD) patients face higher risks for cardiovascular (CV) complications from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This review examines these CV issues in CKD patients, including those on dialysis or post-transplant.
Area of Science:
- Nephrology
- Cardiology
- Infectious Diseases
Background:
- Chronic kidney disease (CKD) significantly elevates cardiovascular (CV) disease risk.
- CKD patients, especially those on dialysis or kidney recipients, experience more severe outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.
- Coronavirus disease 2019 (COVID-19) presents numerous CV complications, including inflammation, events, thrombosis, and arrhythmias.
Approach:
- This review synthesizes current knowledge on cardiovascular complications associated with COVID-19.
- It specifically analyzes the implications of these complications for individuals with chronic kidney disease.
- The review explores proposed pathogenetic mechanisms underlying these CV issues.
Key Points:
- CKD is a major risk factor for severe COVID-19 and subsequent cardiovascular complications.
- Cardiovascular manifestations of COVID-19 in CKD patients range from acute inflammatory responses to long-term events.
- Potential mechanisms include direct viral effects, endothelial dysfunction, and hypercoagulability.
Conclusions:
- COVID-19 poses a substantial threat to cardiovascular health in the CKD population.
- Understanding these risks is crucial for managing CKD patients during and after the pandemic.
- Further research is needed to elucidate specific mechanisms and develop targeted interventions.
Abstract:
Millions of people worldwide have chronic kidney disease (CKD). Affected patients are at high risk for cardiovascular (CV) disease for several reasons. Among various comorbidities, CKD is associated with the more severe forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This is particularly true for patients receiving dialysis or for kidney recipients. From the start of the SARS-CoV-2 pandemic, several CV complications have been observed in affected subjects, spanning acute inflammatory manifestations, CV events, thrombotic episodes and arrythmias. Several pathogenetic mechanisms have been hypothesized, including direct cytopathic viral effects on the myocardium, endothelial damage and hypercoagulability. This spectrum of disease can occur during the acute phase of the infection, but also months after recovery. This review is focussed on the CV complications of coronavirus disease 2019 (COVID-19) with particular interest in their implications for the CKD population.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology

